Cargando…

First person – Suzie Buono and Arnaud Monseur

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Suzie Buono and Arnaud Monseur are co-first authors on ‘ Natural history study and statisti...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346513/
http://dx.doi.org/10.1242/dmm.049681
_version_ 1784761665612414976
collection PubMed
description First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Suzie Buono and Arnaud Monseur are co-first authors on ‘ Natural history study and statistical modeling of disease progression in a preclinical model of myotubular myopathy’, published in DMM. Suzie is a senior associate scientist in the lab of Belinda Cowling at Dynacure, Illkirch, France, investigating rare diseases, especially centronuclear myopathies. Arnaud is a senior manager of statistics and data science at Pharmalex, Mont-St-Guibert, Belgium, working on innovative clinical trials, disease modelling and Bayesian statistics.
format Online
Article
Text
id pubmed-9346513
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-93465132022-08-03 First person – Suzie Buono and Arnaud Monseur Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Suzie Buono and Arnaud Monseur are co-first authors on ‘ Natural history study and statistical modeling of disease progression in a preclinical model of myotubular myopathy’, published in DMM. Suzie is a senior associate scientist in the lab of Belinda Cowling at Dynacure, Illkirch, France, investigating rare diseases, especially centronuclear myopathies. Arnaud is a senior manager of statistics and data science at Pharmalex, Mont-St-Guibert, Belgium, working on innovative clinical trials, disease modelling and Bayesian statistics. The Company of Biologists Ltd 2022-07-25 /pmc/articles/PMC9346513/ http://dx.doi.org/10.1242/dmm.049681 Text en © 2022. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle First Person
First person – Suzie Buono and Arnaud Monseur
title First person – Suzie Buono and Arnaud Monseur
title_full First person – Suzie Buono and Arnaud Monseur
title_fullStr First person – Suzie Buono and Arnaud Monseur
title_full_unstemmed First person – Suzie Buono and Arnaud Monseur
title_short First person – Suzie Buono and Arnaud Monseur
title_sort first person – suzie buono and arnaud monseur
topic First Person
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346513/
http://dx.doi.org/10.1242/dmm.049681